Medical direction and safety

Tenn. Code Ann. § 53-16-106, under HOPE Treatment Act.

Tenn. Code Ann. § 53-16-106

(a) Ibogaine may only be administered in this state:(1) As part of a clinical trial conducted at a hospital or qualified research facility; and(2) Under the medical direction of a physician licensed in this state.

(1) As part of a clinical trial conducted at a hospital or qualified research facility; and

(2) Under the medical direction of a physician licensed in this state.

(b) A research institution that is conducting or participating in a federally authorized clinical trial for ibogaine shall implement appropriate patient screening and safety protocols consistent with federal law, rule, and guidance.